Portfolio Companies
|
Medical imaging technology allowing for reduction of radiation dosage |
Palo Alto, CA www.algomedica.com SHD III |
 Acquired by Allergan plc (NYSE: AGN) in January 2016
|
Aesthetic medicine and medical dermatology products |
New York, NY www.anteriosinc.com SHD I |
|
Pharmaceutical company focusing on the treatment of anger, mood and stress related disorders |
Bethlehem, PA www.azevan.com SHD II |
 Acquired by Volcano Corp. (NasdaqGS: VOLC) in December 2007
|
Invasive arterial imaging using optical coherence tomography technology |
San Antonio, TX www.volcanocorp.com SHD I |
|
Cryoablation technology |
San Francisco, CA www.channelsystems.com SHD II |
|
Pharmaceutical company focusing on the treatment of fibrosis and inflammatory diseases |
Pittsburgh, PA www.complexarx.com SHD II |
 Licensed Substantially All Assets to Sanofi-Aventis (NYSE: SNY) in March 2010
(re-acquired assets in August 2015)
|
Treatment of Type 1 and Type 2 Diabetes via islet neogenesis. |
Wilmington, DE
www.curedm.com SHD I |
|
Medical device focusing on the treatment of migraines, overactive bladder syndrome and urinary incontinence |
San Francisco, CA www.emkinetics.com SHD II |
|
Air purification business utilizing photocatalytic oxidation |
Addison, TX www.garfieldindustries.com SHD I |
|
Emergency preparedness and response software platform |
Boston, MA www.liveprocess.com SHD I |
 Acquired by C.R Bard. (NYSE: CBR) in July 2013
|
Cutting-edge medical inflatables |
Burlingame, CA www.bardpv.com SHD II |
|
Non-invasive molecular skin testing |
South San Francisco, CA www.minderadx.com SHD III |
 |
Technology for early detection of diabetic foot ulcers |
Somerville, MA www.podimetrics.com SHD III |
 |
Foley catheter related technology |
San Francisco, CA www.potreromed.com SHD II |
 |
Minimally invasive circulatory support device |
Houston, TX www.procyrion.com SHD III |
 |
Devices for the treatment of ophthalmic disorders |
Menlo Park, CA www.sightsciences.com SHD II |